Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron- and copper-dependent enzymes are a broad class of metalloproteins that utilize iron (Fe2+/Fe3+) or copper (Cu2+/Cu+) ions as essential cofactors to catalyze a wide range of biochemical reactions (Andreini et al., 2008). These enzymes play pivotal roles in fundamental biological processes such as cellular respiration, DNA synthesis, oxygen transport, and the neutralization of reactive oxygen species (Festa & Thiele, 2011). For instance, iron-dependent prolyl hydroxylases regulate the cellular response to hypoxia, while copper-dependent lysyl oxidases are required for the structural integrity of the extracellular matrix (Kagan & Li, 2003). Dysregulation of these enzymes or the homeostasis of their metal cofactors is implicated in various pathologies, including cancer, neurodegenerative diseases like Alzheimer's, and chronic inflammatory conditions (Bush, 2003). Therapeutic strategies targeting this group include small-molecule inhibitors that bind to the enzyme's active site or chelating agents that sequester the metal cofactors (Hentze et al., 2004). However, the broad distribution and essential nature of these metals across many physiological systems present significant challenges for achieving drug selectivity and minimizing systemic toxicity (Kim et al., 2008).
Inhibition of catalytic activity via active site binding or metal cofactor chelation (Kim et al., 2008).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron- and copper-dependent enzymes.